All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 33 of 45
-
Class IIofficial
Unexo Life Sciences Private Limited recalls HealthWise PERIOD PATCH Menstrual Pain ReliefcGMP Deviations
-
Class IIofficial
Unexo Life Sciences Private Limited recalls EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical AnestheticcGMP Deviations
-
Class IIofficial
Unexo Life Sciences Private Limited recalls LILAS Feminine Pain Relief PatchcGMP Deviations
-
Class IIofficial
Unexo Life Sciences Private Limited recalls JR WATKINS COOLING PAIN RELIEF PATCHEScGMP Deviations
-
Class IIofficial
Unexo Life Sciences Private Limited recalls CHEEKY BONSAI PAIN RELIEF PATCHEScGMP Deviations
-
Class IIofficial
Unexo Life Sciences Private Limited recalls PARCHE LEON PAIN RELIEVING HOT PATCHcGMP Deviations
-
Class IIofficial
Cipla USA, Inc. recalls Lanthanum Carbonate Chewable TabletsFailed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
-
Class IIofficial
Cipla USA, Inc. recalls Lanthanum Carbonate Chewable TabletsFailed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 2.5 mgCGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 5 mgCGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mgCGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Morphine Sulfate Extended-Release Tablets 15 mgFailed Impurities/Degradation Specification
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Morphine Sulfate Extended-Release Tablets 30 mgFailed Impurities/Degradation Specification
-
Class IIofficial
BLI International, Inc. recalls Chlorpheniramine Maleate 4 mg tabletsSuperpotent Drug: Stability failure for assay at 6 months test time-point.
-
Class IIofficial
AvKARE recalls Sunitinib Malate CapsulesLabeling: Label Mix-Up
-
Class IIofficial
AvKARE recalls Sunitinib Malate CapsulesLabeling: Label Mix-Up
-
Class IIofficial
Keystone Industries recalls Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated SolutionSubpotent Drug
-
Class IIofficial
Akron Pharma, Inc. recalls OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener LaxativeCGMP Deviations
-
Class IIIofficial
Padagis US LLC recalls Triamcinolone Acetonide Cream USPSubpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
-
Class IIofficial
Accord Healthcare, Inc. recalls Cinacalcet Tablets 30 mgCGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
-
Class IIofficial
Accord Healthcare, Inc. recalls Cinacalcet TabletsCGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
-
Class IIofficial
Accord Healthcare, Inc. recalls Cinacalcet TabletsCGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Cinacalcet TabletsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Cinacalcet TabletsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Cinacalcet TabletsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
-
Class IIofficial
C & A Naturistics recalls AK Forte Ortiga y Omega 3 Cont. Neto 100 TabletasMarketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
-
Class IIofficial
Neogen Corporation recalls LICEOUTCGMP violations.
-
Class IIofficial
Neogen Corporation recalls LICEOUTCGMP violations.
-
Class IIofficial
Accord Healthcare, Inc. recalls Cisplatin InjectionFailed Impurities/Degradation Specifications.
-
Class IIIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ciclopirox Gel 0.77%Defective Container: Firm received complaints of broken tube at the seal.
-
Class Iofficial
Staska Pharmaceuticals, Inc. recalls Ascorbic Acid Inj. SolutionPresence of Particulate Matter: Presence of glass particulates.
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USPCGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Phenylephrine HCl 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Oxytocin 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls EPINEPHrine 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIofficial
Fresenius Kabi Compounding, LLC recalls Thiamine HCl 0.9% Sodium Chloride Injection USPcGMP violations
-
Class IIIofficial
Denison Pharmaceuticals, LLC recalls Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mgCrystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
-
Class IIIofficial
Denison Pharmaceuticals, LLC recalls Kids' Cough and Chest Congestion (Dextromethorphan HBrCrystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
-
Class IIofficial
Nivagen Pharmaceuticals Inc recalls Atorvastatin Calcium TabletsPresence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal SprayDefective Delivery System: The dip tube is clogged causing the spray not to work.
-
Class IIofficial
Viona Pharmaceuticals Inc recalls Dapsone Gel 7.5%Crystallization
-
Class IIofficial
Advanced Accelerator Applications USA, Inc. recalls PluvictoCGMP deviations
-
Class Iofficial
Gilead Sciences, Inc. recalls Veklury (remdesivir) for injectionPresence of Particulate Matter: Presence of glass particle.
-
Class Iofficial
123Herbals recalls Vail-Bon Jie Yang Wan capsulesMarketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.